Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
New England Journal of Medicine · 07.05.2026 · 394 (18) · 1790-1802
DOI: 10.1056/nejmoa2505783 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, erschienen am 07.05.2026. Verfasst von Brian M Wolpin und 20 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber Cancer Institute, Boston. Hauptthemen laut MEDLINE: Antineoplastic Agents, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Piperazines. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Revolution Medicines.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dana-Farber Cancer Institute, Boston.
- Memorial Sloan Kettering Cancer Center, New York.
- Huntsman Cancer Institute, University of Utah, Salt Lake City.
- NEXT Oncology Virgina, Virgina Cancer Specialists Research Institute, Fairfax.
- Christ Hospital, Cincinnati.
- NEXT Oncology, San Antonio, TX.
ORCID-Profile: Wungki Park
Förderung
- Revolution Medicines
Zitieren
APA
Wolpin, B. M., Park, W., Garrido-Laguna, I., Spira, A., Starodub, A., Sommerhalder, D., Punekar, S. R., Barve, M., Pelster, M., Herzberg, B., Azad, N. S., Hecht, J. R., Ou, S. H. I., Lin, T., Kar, S., Tao, L., Vora, R., Hegde, A., Aung, K., …, & RMC-6236-001 Investigators (2026). Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer. New England Journal of Medicine, 394(18), 1790-1802. https://doi.org/10.1056/nejmoa2505783
Vancouver
Wolpin BM, Park W, Garrido-Laguna I, Spira A, Starodub A, Sommerhalder D, et al. Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer. New England Journal of Medicine. 2026;394(18):1790-1802. doi:10.1056/nejmoa2505783
BibTeX
@article{Wolpin2026,
author = {Wolpin, Brian M and Park, Wungki and Garrido-Laguna, Ignacio and Spira, Alexander and Starodub, Alexander and Sommerhalder, David and Punekar, Salman R and Barve, Minal and Pelster, Meredith and Herzberg, Benjamin and Azad, Nilofer S and Hecht, Joel Randolph and Ou, Sai Hong Ignatius and Lin, Tong and Kar, Sumit and Tao, Lin and Vora, Rashmi and Hegde, Aparna and Aung, Kyaw and Hong, David S and RMC-6236-001 Investigators, RMC-6236-001 Investigators},
title = {Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {18},
pages = {1790--1802},
doi = {10.1056/nejmoa2505783}
}
EUVIMED